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Abstract
Small RNAs are functional molecules that modulate mRNA transcripts and have been implicated in the aetiology of several
common diseases. However, little is known about the extent of their variability within the human population. Here, we
characterise the extent, causes, and effects of naturally occurring variation in expression and sequence of small RNAs from
adipose tissue in relation to genotype, gene expression, and metabolic traits in the MuTHER reference cohort. We profiled
the expression of 15 to 30 base pair RNA molecules in subcutaneous adipose tissue from 131 individuals using high-
throughput sequencing, and quantified levels of 591 microRNAs and small nucleolar RNAs. We identified three genetic
variants and three RNA editing events. Highly expressed small RNAs are more conserved within mammals than average, as
are those with highly variable expression. We identified 14 genetic loci significantly associated with nearby small RNA
expression levels, seven of which also regulate an mRNA transcript level in the same region. In addition, these loci are
enriched for variants significant in genome-wide association studies for body mass index. Contrary to expectation, we found
no evidence for negative correlation between expression level of a microRNA and its target mRNAs. Trunk fat mass, body
mass index, and fasting insulin were associated with more than twenty small RNA expression levels each, while fasting
glucose had no significant associations. This study highlights the similar genetic complexity and shared genetic control of
small RNA and mRNA transcripts, and gives a quantitative picture of small RNA expression variation in the human
population.
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Introduction
A world of noncoding RNA molecules has been uncovered in
the last decades, expanding our understanding of functional
elements in the genome [1]. After it was found that the small
(,15–30 nt) noncoding RNAs can directly modulate protein levels
[2,3], and via that, almost any cellular process [4], they have been
subject to vigorous study, leading to the recognition that several
different types of small RNAs can act as posttranscriptional
regulators [5].
MicroRNA genes (miRNAs) were the first animal small RNA
genes to be discovered [6], and over 1,500 examples have been
found in humans to date [7]. The primary miRNA transcript has a
stem loop structure that is recognised and cleaved via RNA
processing enzymes to produce a double stranded duplex [8]. The
mature miRNA strand is loaded into a complex containing
Argonaute family proteins and guided to targeting, while the other
strand is assumed to be degraded. miRNAs target mRNA
transcripts via base pair complementarity, typically in the 39
untranslated region [8,9], but also coding sequence [10]. This
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targeting can induce transcript cleavage, degradation, destabilisa-
tion, or repression of translation, thus modulating protein levels.
Small nucleolar RNAs (snoRNAs) are typically longer genes (60–
300 nt) that facilitate RNA editing within ribosomal or spliceo-
somal RNAs [11]. However, their full sequences can also be
processed into snoRNA derived RNAs that exert a similar mode of
action as miRNAs [12,13,14].
The recent ability to quantify levels of small RNA expression
invites questions about the extent and causes of their variability in
the human population. Importantly, the quantity and quality of
transcripts are the only way genetic variation can influence
phenotype. Thus, the genetic contribution to small RNA
expression trait variability has to be assessed for accurate
understanding of transmission of heritable information. Such
questions have already been successfully addressed for mRNA
expression levels, where variability between tissues [15], popula-
tions [16], and diseased and healthy individuals [17], as well as the
contribution of genotype [16,18,19,20] have been thoroughly
characterised. Previous studies have found genetic contribution to
miRNA levels in both human fibroblasts [21] as well as adipose
tissue [22] using miRNA microarrays. However, other types of
small RNAs have not been assayed, and a full account of small
RNA sequence and transcriptome variability in a reference cohort
is missing.
Small RNA expression can be viewed as a primary genetic trait
to be mapped in isolation, but also as a quantitative trait with
downstream influences on gene expression and other phenotypes.
Recent studies have been successful in combining information
about genotype and intermediate phenotypes (such as mRNA
levels [17,23,24] or inferred cellular activations [25]) to under-
stand how the genetic signal is mediated. In this light, it is
especially interesting to analyse small RNA transcript levels as
intermediate traits potentially causative for downstream effects, as
both miRNAs and snoRNAs have already been implicated in
many human disease phenotypes ranging from obesity and autism
to cancer [26,27,28,29,30,31,32].
The MuTHER (Multi-Tissue Heritability Resource) cohort was
established with the aim of analysing the genetics of gene
expression in multiple human tissues in over 800 individuals
[19,20,33]. This cohort is a subset of the UK Twins [34], and has
extensive information on genotype and gene expression, as well as
a plethora of clinical phenotypes. We set out to characterise small
RNA variability in 131 abdominal fat samples from MuTHER
resource using high throughput sequencing technology. We
quantified the content of the small RNA transcriptome, the extent
of sequence and transcript level variation, the relative levels of
miRNA expression from both arms of the molecule, as well as
coexpression of miRNAs from the same cluster. Since high density
genotype data, mRNA levels from the same RNA sample as well
as obesity-related phenotypes were available for these individuals,
we associated these measurements with the small RNA levels to
find out about the extent of genetic control, mRNA and miRNA
expression correlates, and relation of small RNAs and global
metabolic traits.
Results
Largest small RNA sequencing dataset to date
We sequenced subcutaneous adipose tissue small RNAs of 131
females from the UK TWINS cohort [34] included in the
MuTHER study [19] on the Illumina GAII platform (Materials
and Methods, data available at the EGA, submission ID
EGAS00001000212). After filtering, quality control, and mapping,
we obtained 331 million total reads, with a median of 2.3 million
reads per sample aligning to the genome (Materials and Methods,
Figure S1). The majority of the reads (93%) mapped to annotated
mature miRNA sequences (mirBase v17 [7]), with the rest divided
between tRNAs (2%), snoRNAs (0.6%), lincRNAs (0.3%), and
other noncoding RNA features annotated in Ensembl v63 [35]
(Table S1). This distribution is expected, as we size-selected for
15–30 base pair fragments, which excludes other functional RNA
species except for degradation products. In addition, we found
reads mapped to loci previously unannotated for noncoding RNA
transcription. We identified 12 novel miRNA gene candidates
using MapMi ([36], Materials and Methods, Dataset S1), and 701
short (,100 bp) regions with at least 1000 total mapped reads
across all samples (2% of all mapped reads, Table S2). These
regions were significantly enriched in DNAse hypersensitivity sites
(237/701, one-tailed binomial p,10210, Materials and Methods),
which often harbour enhancer elements that are known to give rise
to short transcripts [37]. The rest overlapped exons (149/701, one-
tailed binomial p,10210) and introns (190/701, not significant),
with 233 regions arising from intergenic sequence.
Highly expressed miRNAs are implicated in adipose and
blood cell development
We quantified expression levels of 418 known miRNA gene
products, 239 tRNAs, 173 snoRNAs, 111 lincRNAs and 107 other
RNAs that had at least 1000 total sequencing reads (Figure 1A,
Table S1). For further analyses, we focused on miRNAs and
snoRNA derived sequences as the only known functional
molecules in our selected size range. The adipose tissue small
RNA transcriptome is of medium complexity, with a median of 17
species of molecules required to account for 75% of the mapped
reads (Figure 1B). The most highly expressed small RNAs
(Figure 2A) have previously been associated with adipose
development (mir-143-3p [38], mir-21-5p [12]), angiogenesis
(mir-126-3p [39], mir-378a-3p [40]), and erythropoiesis (mir-24-
3p [41], mir-451a [42]). We compared the average expression
levels in adipose tissue to public human small RNA sequencing
data from B-cells [43], liver [44], pigment cells [45], pooled
thymocytes, bone marrow, CD34+ progenitor cells [46], lung,
kidney, skeletal muscle, heart, pancreas, frontal orbital gyrus,
spleen, and liver tissue [47] after processing them with our
pipelines (Materials and Methods, Table S3). While seven of the
ten most highly expressed small RNA genes and gene families
were highly expressed in all tissues (let7 family, mir-24-3p, mir-
378a-3p, mir-21-5p) other highly expressed small RNAs (mir-143-
Author Summary
Genetic information is transmitted to the cell only through
RNA molecules. A special class of RNAs is comprised of the
small (up to 30 nucleotide) ones, known to be potent
regulators of various cellular processes. At the same time,
they have not been as widely studied as messenger
RNAs—we do not know how much variation in their
sequence and expression level occurs naturally in human
populations or how this variability influences other traits.
We measured small RNA levels and genetic variability in fat
tissue from 131 individuals by high-throughput sequenc-
ing. We could associate the expression levels with genetic
background of the individuals, as well as changes in
metabolic traits. Surprisingly, we found no large scale
influence of small RNA variation on mRNA levels, their
main regulatory target. Overall, our study is the first to give
a quantitative picture of the naturally occurring variation in
these important regulatory molecules in human fat tissue.
Human Adipose Small RNA Variation
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3p, mir-126-3p) were specific to adipose tissue (average q-value of
pairwise comparisons ,0.1, Materials and Methods). In total,
there were 12 miRNAs with significantly higher expression
(q,0.1) compared to mean of every other tissue, and no such
snoRNAs, with mir-126-3p, mir-340-3p, mir-190a, and mir-335-
3p showing the strongest specificity signal (Figure 2B).
Expressed miRNA and snoRNA genes have reduced
genetic variability
Next, we called variants from the RNA sequence data
(Materials and Methods), and found one mature miRNA and
two snoRNA polymorphisms, all with independent evidence from
whole genome sequencing of the UK10K cohort (personal
communication, UK10K Consortium) (Table S4). All three found
variants had relatively low (,11%) minor allele frequency (MAF).
Assuming Hardy-Weinberg equilibrium, and equal expression
from both gene copies, the miRNA sequence variant represents a
fraction of 761025 of the 14,005 mature miRNA and star
sequence sites that could pass our filters, consistent with previous
reports of strong purifying selection in the functional small RNA
regions [48]. The same regions in the UK10K project harboured
13 called polymorphic sites, 9 of which had MAF,1%. We
detected one of these sites using small RNA sequencing
(MAF = 11%), and did not find the rest. Based on the MAF of
each UK10K DNA variant, and expression levels of the small
RNAs, we expected to recover one additional site (Materials and
Methods). While it is possible that other polymorphisms are
present in sequences coding for miRNA and snoRNA products,
the derived alleles were not observed on at least 10 reads in our
data, and could thus not be reliably detected. In addition to
genetic variants, we found three A to I RNA editing events in the
mature miRNA regions (Materials and Methods, Table S4). These
sites were the 7th, 8th, and 9th bases of the mature product, and
edited in 25, 18, and 11 percent of the reads, indicating that
additional variability is tolerated in the functionally important seed
region. We also observed bases at the ends of mapped reads not
matching the genome in line with previous reports ([49], Table
S5), but as similar discrepancies were not observed at comparable
frequency in the data from other tissues, we considered them more
likely to be sequencing or library preparation artefacts than true
RNA modifications.
Genetically variable small RNAs have low expression level
and variation
As mature miRNA sequences and analogous snoRNA products
function via base pair complementarity, there is selective pressure
against accumulating variants in their regions. Previous reports
from DNA sequence data have confirmed increased conservation
of miRNA sequence compared to intronic and intergenic
background, but also a more pronounced effect for more highly
expressed genes. We also observed a lack of miRNAs with at least
1000 reads on average and UCSC primate conservation score of
less than 0 (Figure 3A, p,361025, chi-squared test, Materials and
Methods). Moreover, we assessed if the variability in the
expression levels is under similar influence. Indeed, we observed
a lack of small RNAs with expression variance of at least 5, and a
conservation score below 0 (Figure 3B, nominal p,361024, chi-
squared test), suggesting that selection acts on not just average
expression, but also expression variation.
Batch effects and covariates have a strong effect on
expression levels
After analysing the variability of RNA expression levels within
and between tissues, we next addressed inter-individual varia-
tion. First, we tested whether experimental confounders influ-
enced small RNA expression variability between samples. To this
end, we performed principal components analysis of log-
transformed, normalised read counts (Materials and Methods,
Tables S6 and S7), and associated first twenty components (PCs)
to known covariates of sample multiplexing tag, library batch,
sequencing flow cell, RNA integrity score (RIN, [51]), and RNA
concentration (Materials and Methods). We found significant
associations (Bonferroni-corrected p,0.05) for RIN (PC1),
library batches (PC1, 2, 3, 6, 10, 11, 12, 13, 18), and two
multiplexing tags (PC5, 14). As these components capture major
directions of variation in the data, we included the associated
covariates measured for all samples (age, library batch and
multiplexing tag) in eventual analyses. Since it has been
demonstrated that unmeasured confounders similarly have an
influence on expression levels [52,53], we tested whether
applying the Bayesian factor analysis package PEER [54], to
account for these confounders, increases the number of
discoveries. As we already corrected for 30 known covariates,
Figure 1. Summaries of sequenced small RNAs. A. Cumulative number of different small RNA species recovered at required minimum coverage
of 1000 total mapped reads (approximately 8 reads per sample, red line). B. Cumulative fraction of mapped reads accounted for by the most highly
expressed small RNAs for twelve randomly chosen samples, with 75th percentile marked with the dashed line.
doi:10.1371/journal.pgen.1002704.g001
Human Adipose Small RNA Variation
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including the additional inferred factors did not increase findings
in downstream analyses, and were not used.
Small RNA levels are associated with genotype
To identify miRNA and snoRNA genes whose expression is
driven by cis-acting genetic variation, we performed association
tests between their transcript levels and SNPs within 100 kb of the
transcript (Materials and Methods). We found significant cis-
eQTLs (nominal p,2.461024, FDR,5%) for eight of 418
miRNAs and six of 173 snoRNAs (Table 1). In comparison, 462
eQTLs were found for 27,499 mRNA probes in the same tissue
and cohort with comparable sample size and FDR in a previous
study [19], suggesting a similar level of genetic control for mRNA
and small RNA transcript levels.
We validated our eQTL findings in an independent cohort of 70
human samples with array-based miRNA expression data from
abdominal adipose tissue [22]. Five of the eight miRNAs with an
eQTL in our study were assayed in this study, with three of them
replicating (nominal p,0.05, Table S8) and p-values across the
full set of eQTLs tested in each study concordant (Spearman rank
correlation p,861024, Figure S2). However, we found no overlap
between our significant cis-eQTL results and 12 significant
(p,0.05 from 10,000 permutations) miRNA cis-eQTLs reported
in human fibroblasts [21], likely due to a different set of expressed
genes and lack of replication power. As mRNA studies in larger
cohorts have found only up to a third of genetic associations to be
tissue-specific [19,55], we also expect many of the small RNA
eQTLs to have an effect in other tissues in better powered studies.
Figure 2. Most highly expressed and most adipose-specific small RNA genes. Most highly expressed (A) and most adipose-specific (B) small
RNA genes, their relative expression level in B-cells [43], liver [44], pigment cells [45], pooled thymocytes, bone marrow, CD34+ progenitor cells [46],
lung, kidney, skeletal muscle, heart, pancreas, frontal orbital gyrus, spleen and liver [47]. The annotated function of the miRNAs is given on the right,
with information for mature miRNAs (M) given for some of the sequences from the other miRNA arm that did not have independent annotation.
doi:10.1371/journal.pgen.1002704.g002
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The full MuTHER cohort of 776 individuals was profiled for
mRNA levels from adipose tissue using the same RNA sample for the
individuals in our study, as well as skin and lymphoblastoid cell lines
from a separate RNA sample. Thus, we could directly assess any
overlap in genetic control of transcripts of different type and across
multiple tissues. We found seven of our small RNA eQTL SNPs to
also be significantly associated with a nearby mRNA probe (Table 2).
The mRNA transcripts were the nearest annotated transcript to the
two miRNAs and two snoRNAs, but at least one and up to four
annotated mRNA transcripts away from the rest of the snoRNAs.
Further, in three of the eight cases, the mRNA and small RNA did
not share the direction of the SNP effect. This suggests nontrivial
shared genetic control, either via enhancer or promoter, or a single
transcript that is spliced to form multiple genes.
Small RNA expression levels are associated with obesity-
related phenotypes
As our cohort has been phenotyped for DEXA-derived
measurements of percentage trunk fat mass (PTFM), BMI, fasting
insulin, and fasting glucose (summaries in Table S9), we examined
the association between small RNA expression and these obesity-
related phenotypes (Materials and Methods). We found 47, 41 and
23 out of the 591 tested small RNAs to be associated with PTFM,
BMI and fasting insulin respectively (per-trait FDR,5%). As these
traits are highly correlated (Pearson’s r.0.45 for all pairwise
comparisons), there is also considerable overlap in the associated
small RNAs between the traits (Table 3).
Fourteen small RNAs were highly significantly associated with
at least one of the phenotypes (FDR,0.1%, Table 3, miRNA
targets and functional enrichment analysis [56] in Table S10,
Figure S3, S4). As a complement to the association analysis, we
also contrasted small RNA gene expression levels between lean
(BMI,25; n = 45) and obese (BMI.30; n = 36) subjects, and
found that 43 small RNAs showed significant differences between
the two groups (FDR,0.05, p,5.761023, Table S11), including
all significant hits from Table 3.
Four of the phenotype-associated small RNAs have previously
been associated with metabolic phenotypes and/or adipogenesis.
Figure 3. Lack of small RNAs. Lack of small RNAs with low mammalian conservation score (UCSC Genome Browser [50], y-axis) and high average
(A) or variance (B) of expression level (x-axis). Each dot represents a single miRNA or snoRNA gene.
doi:10.1371/journal.pgen.1002704.g003
Table 1. Small RNA cis-eQTLs - significant (nominal p,2.461024, FDR,5%) associations of miRNA and snoRNA expression levels
to SNPs within 100 kb from the transcript.
small RNA ID Type Chr Start End SNP ID Position P-Value Q-Value
SNORA20 snoRNA 6 160201281 160201415 rs7758895 160193465 1.32E-24 8.18E-21
SNORA25 snoRNA 11 93463678 93463814 rs10160552 93422613 1.35E-15 2.97E-12
SNORD14D snoRNA 11 122929616 122929705 rs1461496 122929624 1.26E-14 2.41E-11
SNORD45B snoRNA 1 76255161 76255235 rs4949677 76266662 3.37E-09 3.49E-06
SNORD18A snoRNA 15 66795580 66795654 rs2053005 66704449 6.83E-09 6.55E-06
hsa-miR-184 miRNA 15 79502178 79502210 rs8033963 79455350 1.98E-06 1.03E-03
hsa-miR-1307-3p miRNA 10 105154052 105154084 rs2986039 105250435 6.31E-06 2.59E-03
hsa-miR-378d miRNA 4 5925001 5925030 rs13146468 5910469 7.84E-06 3.11E-03
SNORA65 snoRNA 9 130210779 130210911 rs2253411 130232909 2.26E-05 7.74E-03
hsa-miR-195-3p miRNA 17 6920941 6920973 rs2440129 6906571 2.44E-05 8.21E-03
hsa-miR-653 miRNA 7 93112129 93112160 rs16868443 93206264 1.40E-04 3.29E-02
hsa-miR-197-3p miRNA 1 110141558 110141590 rs6658641 110153198 1.60E-04 3.63E-02
hsa-let-7i-5p miRNA 12 62997467 62997499 rs11174580 63044243 2.00E-04 4.48E-02
hsa-miR-2355-3p miRNA 2 207974717 207974749 rs10170608 207983805 2.20E-04 4.78E-02
doi:10.1371/journal.pgen.1002704.t001
Human Adipose Small RNA Variation
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In a recent study, mir-1179 was found to be significantly associated
(FDR,5%) with metabolic syndrome case control status, with
lower expression levels in cases [22]. Here, we report similar
associations between mir-1179 and obesity phenotypes with lower
expression levels associated with increasing BMI, PTFM and FI,
all of which are major components of metabolic syndrome. Mir-
21, here significantly associated with obesity phenotypes (Table 3),
has been reported to be involved in regulation of adipogenesis and
lipid metabolism through its gene targets TGFBR2 and PPARalpha
respectively [57]. Furthermore, mir-21 as well as mir-146b have
been reported to be expressed at higher levels in skin tissue from
diabetic mice [58], and in response to glucose stimulation in
mouse adipocytes [59,60]. Overexpression of mir-29 isoforms in
mouse adipocytes resulted in an insulin resistant phenotype [59].
In a recent study, carried out in mouse islets, isoforms of mir-29
were found to contribute to the beta-cell-specific silencing of
MCT1 (SLC16A1) expression required for appropriate insulin
secretion [61]. In our study, mir-29b-2-5p was significantly
associated BMI and fasting insulin, but not PTFM. Immune
processes have previously been found to be enriched among
mRNAs associated with metabolic phenotypes [17,62], and mir-
146a involved in inflammatory processes [63] and innate
immunity [64] was here found to be associated with PTFM,
BMI and insulin.
Genetic control of small RNA expression associated with
obesity-related traits
We overlapped the SNPs for our 14 significant cis-eQTLs (cis-
SNPs), with SNPs that are directly associated with obesity-related
phenotypes in published genome wide association study (GWAS)
data [65]. Four of the cis-SNPs were associated (nominal p,0.05)
with body mass index (BMI) [65], one each with waist-hip-ratio
adjusted for BMI (WHRadjBMI) [65], low density lipoprotein
(LDL) high density lipoprotein (HDL), and total cholesterol (TC),
and none with triglycerides (TG) [66] (Table 4).
While on the whole, none of the cis-SNPs were genome-wide
significant in the GWAS data, they were significantly enriched for
nominally significant (p,0.05) SNPs in the BMI GWAS results
Table 3. Top 14 associations between small RNA expression
levels and percent trunk fat mass (PTFM), body mass index
(BMI), and fasting insulin (FI), ordered by lowest q-value.
small RNA ID Chr P_PTFM Q_PTFM P_BMI Q_BMI P_FI Q_FI
hsa-miR-146b-3p 10 1.5E-14 8.3E-12 1.9E-09 4.8E-07 2.0E-05 3.4E-03
hsa-miR-146b-5p 10 7.3E-13 2.0E-10 2.2E-11 1.2E-08 4.2E-08 2.9E-05
hsa-miR-215 1 7.8E-08 1.4E-05 1.4E-07 2.4E-05 4.8E-03 1.0E-01
hsa-miR-21-5p 17 3.5E-07 3.9E-05 2.6E-05 1.3E-03 2.5E-06 8.4E-04
hsa-miR-1179 15 3.9E-07 3.9E-05 1.7E-06 1.8E-04 1.4E-03 4.7E-02
hsa-miR-146a-5p 5 4.3E-07 3.9E-05 1.1E-05 6.2E-04 3.0E-05 3.4E-03
hsa-miR-340-3p 5 4.8E-05 2.6E-03 1.6E-06 1.8E-04 2.6E-02 3.0E-01
hsa-miR-193a-5p 17 1.9E-03 3.0E-02 2.8E-06 2.4E-04 3.6E-04 2.1E-02
hsa-miR-181a-2-3p 9 4.0E-06 2.6E-03 8.6E-06 6.2E-04 5.6E-03 1.1E-01
hsa-miR-4421 1 1.4E-03 2.4E-02 1.4E-04 3.5E-03 7.1E-06 1.6E-03
hsa-miR-598 8 1.3E-04 4.7E-03 9.9E-06 6.2E-04 2.2E-01 6.8E-01
hsa-miR-218-2-3p 5 1.5E-05 1.0E-03 4.7E-04 8.6E-03 1.6E-04 1.2E-02
hsa-miR-218-5p 4 1.8E-05 1.1E-03 5.3E-04 9.0E-03 1.8E-04 1.2E-02
hsa-miR-29b-2-5p 1 5.1E-02 3.1E-01 1.9E-05 1.0E-03 2.4E-04 1.5E-02
doi:10.1371/journal.pgen.1002704.t003
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([65], binomial p = 0.007), indicating either their pleiotropic effect,
or metabolic trait regulation through small RNA expression levels.
rs2440129 was nominally significant in the BMI GWAS lookup
[65], while mir-195-3p was significantly associated with both
rs2440129 in cis (FDR,5%, p,2.461025), as well as BMI
(FDR,5%, p,3.961023) and PTFM (FDR,5%, p,4.161023),
suggesting a mechanism for the rs2440129 association. Rs6658641
has a significant (FDR,5%, p,1.661024) cis association with
mir-197-3p in our data (Table 1), GNAI3 mRNA in three tissues
(Table 2), as well as nominally significant associations to metabolic
traits in GWAS. As mir-197 has been reported to regulate the
expression of tumour suppressor gene FUS1 [67] and to be
upregulated in type two diabetes patients [32], it is plausible that
the effect of rs6658641 genotype on downstream expression and
metabolic traits is mediated via the miRNA expression level.
miRNAs from the same cluster are correlated in
expression, while miRNAs and mRNAs from the same
transcript are not
miRNA genes are either processed from intronic mRNA
sequence, or transcribed from endogenous promoters [68]. A single
miRNA promoter can give rise to a transcript that includes a cluster
of miRNAs that are then individually cleaved [69]. We tested
whether pairwise correlations between expression levels of miRNAs
in the same cluster (defined by Saini et al. [68] to be within a 10 kb
block) are larger than those between random miRNAs, and found
significant enrichment of positive correlation (Materials and
Methods, Figure S5). The median of median pairwise correlations
between cluster member expression levels was 0.37, compared to
0.03 of random miRNA sets of same size (p,1028, Mann-Whitney
U test). On the other hand, we found little evidence for relation
between miRNA expression level and expression of its nearest
mRNA probe. The distribution of correlation coefficients was
centered on zero, without a heavy tail of positive correlation (Figure
S6), a statistically significant difference to distribution of random
small RNA-mRNA pairs (p.0.37, Mann-Whitney U test), or a
trend for higher correlation for less distant probes. This shows that
mRNA transcript levels are not good predictors of intronic miRNA
levels in our dataset, and suggests that more miRNAs are expressed
from an endogenous promoter than commonly appreciated, in line
with recent findings [69,70,71].
There is little evidence for abundance of negative
correlation between mRNA and miRNA levels
One of the two modes of miRNA action is directly regulating
the transcript level via influencing the stability of the transcript, or
direct cleavage [72]. To test whether variability in the miRNA
expression levels is related to variability in its target mRNA
expression, we calculated correlations between miRNA expression
levels and their validated mRNA targets from miRecords [73] or
predicted mRNA targets from tarBase v5 [74] both with and
without accounting for experimental confounders in mRNA and
miRNA data sets (Materials and Methods). To our surprise, we
found that the average correlation between miRNA expression
levels and their 522 validated targets was 20.012, and their
194,205 predicted targets 20.004. While these averages are
statistically significantly less than 0 (one-sample t-test p,0.05 and
1025 respectively), they indicate no strong enrichment of extreme
negative correlations compared to random miRNA-mRNA pairs
(Figure S7). We also tested whether the miRNA seed sequences are
overrepresented in the 39 UTR regions of the mRNA expression
levels most negatively correlated to the miRNA using Sylamer
([75], Methods). Again, we found no evidence for significant
enrichment (all q-values.0.5). This suggests that at a genome-
wide level inter-individual variation of small RNA expression
levels in our reference cohort does not have a detectably large
effect on mRNA expression.
Expression ratio between miRNA arms varies across
genes and individuals
The mature miRNA is processed from a double-stranded RNA
hairpin by the Dicer RNAse [72], with the other arm assumed to
be degraded [76]. The basis for choosing one of the hairpin arms
as a mature product, and the extent to which the alternate arm
(the less commonly observed product, previously also referred to as
the star sequence) is functional, are not well understood
[77,78,79]. To assess the extent of expression of both arms, and
the variability of the relative expression ratio, we quantified the
expression level of the alternate arm for 63 miRNAs. Other
miRNA genes had only one arm detectably expressed, and only
eight out of the 63 alternate arms were expressed at average level
of at least 250 reads per sample. For seven miRNA genes, the
alternate arm was on average more highly expressed compared to
the mature product according to miRBase (Figure S8). Looking at
variation between individuals, we found 12 mature sequence
expression levels to be significantly correlated with their alternate
arm sequence expression level (|Spearman’s rho|.0.4, nominal
p,261025). For mir-186 and mir-29a, high abundance of the
alternate arm sequence was indicative of low mature sequence
levels, suggesting mutually exclusive selection of the arms. As the
arm choice is suggested to be influenced by the nearby RNA
Table 4. Overlap of cis-eQTLs (FDR,5%, p,2.461024) and GWAS SNPs nominally significant (p,0.05) for body mass index (BMI),
waist-hip-ratio adjusted for BMI (WHR(adjBMI)), low density lipoprotein (LDL), high density lipoprotein (HDL), and total cholesterol
(TC).
SNP ID small RNA ID Type Chr P-value eQTL P-value GWAS GWAS phenotype
rs8033963 hsa-miR-184 mature-miRNA 15 1.98E-06 1.01E-02 BMI
rs6658641 hsa-miR-197-3p mature-miRNA 1 1.57E-04 4.93E-02 BMI
rs2440129 hsa-miR-195-3p mature-miRNA 17 2.44E-05 3.58E-02 BMI
rs2053005 SNORD18A snoRNA 15 6.83E-09 4.57E-02 BMI
rs16868443 hsa-miR-653 mature-miRNA 7 1.38E-04 3.70E-02 WHR(adjBMI)
rs6658641 hsa-miR-197-3p mature-miRNA 1 1.57E-04 7.89E-04 LDL
rs2986039 hsa-miR-1307-3p mature-miRNA 10 6.31E-06 1.84E-02 HDL
rs6658641 hsa-miR-197-3p mature-miRNA 1 1.57E-04 1.14E-03 TC
doi:10.1371/journal.pgen.1002704.t004
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context [78,80], we tested for whether DNA variants in the region
are correlated with the relative abundance of sequence from the
two arms. We found SNP rs13174179 to be associated with the
expression difference of miR-378 arms (nominal p = 5.361024,
FDR,10%).
Discussion
We have presented the largest small RNA sequencing dataset in
a human reference cohort to date, and demonstrated the extent,
causes, and consequences of the variability in small RNA
expression.
Extent of variability
In spite of the medium complexity of the small RNA
transcriptome, we quantified close to 1,000 different small RNA
species. The highly expressed small RNAs fell into two categories
in terms of inter-tissue variability - adipose-specific, and ubiqui-
tously expressed microRNAs, corroborating previous observations
[81,82]. We confirmed that small RNA sequences have low
genetic variability. This finding was especially pronounced for
small RNAs highly expressed in the tissue we assayed, as only three
derived alleles and three editing events were found. Additional
genetic variants have been seen using DNA sequencing methods,
but their potential functional impact remains to be assessed in
other tissues where the genes are expressed above background
level. Purifying selection acting on highly expressed as well as
highly variable small RNAs was evident from their high
conservation throughout the mammalian lineage, reiterating the
importance of these functional molecules.
Causes of variability
Unexpectedly, some of the largest sources of variability in our
data were due to the experimental protocol. The barcoding
method used in this study, whereby the indexing tag and the
unknown RNA are sequenced in the same read, caused a bias in
terms of the profile of small RNAs that were captured. This could
be addressed by using a generic 59 adaptor and one that
incorporates the indexing tag via PCR, such that the RNA
sequence and the indexing tag are determined in separate reads, or
performing the reverse transcription step directly on the flow cell
[83]. Similar issues with tag bias have been observed and
addressed in recent work published after the experiments reported
here were carried out [84,85]. Additional limitations for the library
preparation were the quality and quantity of the starting material.
Although not always feasible in a clinical situation, every attempt
should be made to ensure that the quality of the total RNA is of a
very high standard (minimum RIN of 8), and it is subject to
minimal handling and freeze/thaw cycles prior to library
construction. These considerations forced us to employ statistical
methods to account for batch effects due to multiplexing tags, and
to drop 37 samples from our initial design due to poor RNA
quality.
Differences in sample preparation and sequencing platform
introduce technical variation that biases and reduces the power of
direct comparisons between small RNA sequencing studies [86].
We limited such confounding effects on our assessment of small
RNA expression tissue specificity by using only Illumina short read
data from other studies, and treating their raw reads in an identical
manner to our samples. While we do not expect this to fully
mitigate the problem, we do not expect that the residual bias
produces the reported large differences between tissues. These
considerations do not affect the rest of our analysis, for which the
small RNA and mRNA data were collected from the same RNA
samples, and genotyping and phenotyping were performed on the
same individuals.
Another important issue for comparing RNA levels between
samples and finding genetic associations was mapping bias due to
sequence variants. Previously uncharacterised polymorphisms
resulted in fewer reads mapped to samples with derived alleles,
which also created a significant eQTL at a known linked SNP. We
recommend projects using small RNA sequencing to employ our
technique of including known genetic variation in the reference
sequence, and to use an ambiguity aware aligner, such as
NovoAlign, to avoid such pitfalls.
Correcting for these technical issues, we were able to explore the
biological causes of small RNA expression variation. We found
genetic associations at a rate comparable with mRNA transcripts,
and replicated them in an independent cohort. Unexpectedly, we
found eight cases of a locus genotype influencing expression levels
of a nearby mRNA and a nearby small RNA, where in four of
these cases the two were unlikely to share a transcript as they were
separated by at least one additional transcribed region. This
highlights that cis, or proximal signal does not have to be contained
to the near vicinity of the transcript, and that distal regulatory sites
are shared between multiple genes.
We also looked for coordinated transcription by direct
correlation of nearby transcripts. Small RNAs are known to be
expressed in clusters from a shared promoter, as well as cleaved
from intronic RNA sequence [68]. While we found support for
increased correlation between miRNAs from the same cluster, we
did not see a global signal for correlation between intronic
miRNAs and their nearest mRNA probe expression. Previous
results have shown a strong relationship between average tissue
mRNA expression level and the intronic miRNA expression [81],
but our results suggest the additional variability around the
average level is not as tightly linked, possibly due to an
independent promoter of the miRNA, or additional postprocessing
regulation of the spliced mRNA transcript.
Finally, phenotypic and environmental differences can and do
elicit changes in the transcriptome. To this end, we found 51 small
RNA genes whose expression level is significantly associated with
metabolic phenotypes available for our cohort. Given the strength
of the observed signal, it is not possible without additional
information to distinguish between causal, reactive, and common
cause models for the relationship between the expression and
phenotype traits. Studies in mouse models and human cohorts
have shown that environmental factors, such as diet, can influence
the expression of both mRNA [87] as well as small RNA [88] in
adipose tissue. We used fat biopsies taken from individuals who
had been instructed to fast the day of the biopsy to control for
potential confounding effect of the daily food consumption, but
long term dietary behaviour was not available for these samples
and thus could not be analysed. Modelling potential hidden causes
of variation in the expression data did not increase the number of
discoveries, suggesting that even if the environmental factors were
observed, they could not be accounted for in a simple linear
manner. Despite this, we can not infer in general that the
phenotypic variability is due to changes in small RNA expression.
In some cases however, previous findings suggest a plausible
regulatory effect of small RNAs on phenotypes as highlighted in
the results.
The MuTHER cohort was set up with the aim to assess
heritability of gene expression in different tissues using twins.
However, as using highly related subjects reduces the power to
map eQTLs using association, we focused our resources on
unrelated individuals in the clinically relevant adipose tissue for
which related phenotype data and an eQTL replication cohort
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were available. Analysing multiple tissues, or employing a co-twin
design to provide heritability estimates and immediate replication
of the results could be followed up from this pilot study.
Consequences of variability
A major goal of this study was to assess the effect of naturally
occurring variation in miRNA expression levels on the mRNA
levels. However, we found no evidence for miRNA expression
variation to be correlated with target mRNA variation. This
negative result cannot be due to the amount of noise in our data
alone, as we could successfully detect genetic effects and phenotype
correlations. Thus, the strength of association between natural
variation of miRNA expression and variation in their target
mRNA expression is limited to a smaller scale than that of genetic
control or downstream effects of global metabolic phenotypes.
This lack of tight target regulation supports the growing body of
evidence [22] that quantitative variation of small RNA expression
within a tissue does not have even a moderately sized effect on its
target mRNA levels, and is consistent with a primary role of
miRNAs being to buffer mRNA levels, for example to a random
fluctuations of transcriptional regulators.
The small effect size of drastic miRNA level perturbation via
knockdown, transfection, or overexpression of a single miRNA on
its target mRNA expression levels has already been shown in
several recent studies in human cell lines. For example, the median
log2 expression level change of the top 150 TargetScan conserved
targets was 0.096 (6.9%) for mir-29 knockdown in fetal lung
fibroblasts [89], 0.131 (9.5%) for mir-145 transfection of MB-231
breast cancer cells [90], 0.173 (12.7%) for mir-30 overexpression
in melanoma cell lines [91], and 0.465 (38.0%) for mir-7
overexpression in A549 cancer cells [92]. Thus, even for these
extreme perturbations of miRNA levels, the observed effects on
the target mRNAs are not pronounced. It is therefore not
surprising that the naturally occurring inter-individual variation
also does not have a large effect.
For the first time, we were able to assess the expression variation
of both microRNA arms. We found that while the alternative arms
(star sequences) are not highly expressed in general, there are
several of them that are not degraded, and are expressed at
appreciable levels. We also observed examples of high mature
miRNA expression being correlated with low expression of the
alternate arm, and a relatively strong genetic signal for arm choice
of one miRNA.
Materials and Methods
Samples and phenotypes
The unrelated individuals included in this study are part of the
MuTHER study of Caucasian females (median age 58) recruited
from the UK Adult Twin Registry (TwinsUK, [34]). Punch
biopsies (8 mm) were taken from a relatively photo-protected area
adjacent and inferior to the umbilicus, subcutaneous adipose tissue
was dissected followed by DNA and RNA extraction as described
in [20]. For inclusion in this study the requirements were that the
individuals were not under hormone replacement therapy, and did
not have confirmed Diabetes Mellitus Type 2. Subjects were
instructed to fast on the day of the biopsy to avoid potential biases
due to food consumption. We used genotypes obtained, filtered
and imputed to HapMap2 as described in [20]. The previously
published gene expression values [20] were obtained using the
Illumina Human HT-12 V3 BeadChips, followed by filtering and
normalisation, and are available at the ArrayExpress [93] (www.
ebi.ac.uk/arrayexpress) under accession number E-TABM-1140.
Metabolic phenotypes were measured at the same time point as
the biopsies and were collected as previously described, including
BMI [94], DEXA measurements of percentage trunk fat mass,
fasting glucose [95] and fasting insulin [96].
Library preparation and sequencing
Only samples with good quality total RNA (no visible
degradation in BioAnalyzer profile and RIN scores in excess of
6.7) were selected for small RNA isolation. Low molecular weight
RNA (,40 nucleotides) was size-selected from between 0.5 to
1.0 mg total RNA using a flashPAGE Fractionator (Ambion,
Austin, TX, USA). The recovered small RNAs were first ligated to
the Illumina v1.5 small RNA 39 adaptor (Illumina, Inc., San
Diego, CA, USA) using T4 RNA ligase 2- truncated (New
England Biolabs, Ipswich, MA, USA). This was followed by a
second ligation, using T4 RNA ligase 1, to one of twelve modified
Illumina SRA 59 adaptors, each with a six-base index tag at the 39
end (Sigma-Aldrich, Haverhill, UK). Both ligation steps were
performed according to the Illumina v1.5 protocol. The 59 and 39
adaptor-ligated small RNAs were immediately reverse transcribed,
amplified and size-selected as described in the Illumina v1.5
protocol. The completed cDNA libraries were pooled (12 libraries
per pool) in equimolar amounts and were sequenced using 37 base
reads on the Illumina GAII platform.
Raw data analysis
Raw sequencing data was obtained in FASTQ format, and
processed with R [97](Bioconductor [98,99], Biostrings and
ShortRead [98,99] packages) and python scripts. We first assigned
the raw reads to their corresponding multiplexing tags. For this,
we calculated the edit distance of the first six bases to all 12 index
tag sequences used in the study, considering 0.25 as the distance
between N and any other base. Reads with edit distances of at least
2.75 to all tags were discarded as well as those with the same
minimum edit distance to more than one tag. The remaining reads
were assigned to the library corresponding to the shortest edit
distance, and their first six bases were removed before proceeding.
The next step consisted of locating and trimming sequences
matching the small RNA 39 adaptor using the trimLRPatterns
function and allowing for mismatches of up to 20% of the
alignment length. The first 12 bases of the 39 adaptor sequence
were allowed to align to any location within the short reads, and if
no alignment was found, a shortened adaptor sequence was
realigned iteratively by removing one base from the 39 end and
anchoring the alignment to the 39 end of the short reads. To
further clean up the short reads to help avoid ambiguous
mappings, any window of five bases with at least three Ns was
located and the read was trimmed starting at the position of the
first N. Any occurrence of an N within two bases of the 39 end of
the read was also trimmed. The reads were then low-complexity
filtered to remove those with .= 90% of a single base. After all
filtering steps, reads with less than 16 bases were discarded. All
remaining read sequences should correspond to short RNA
molecules present in the samples, and length histograms were
produced to confirm the enrichment of a miRNA peak around 22
bases.
Mapping and quantification
Accurate quantification of small RNA molecule counts from
read data is challenging due to genetic variation in the sequence,
ambiguities in read mapping, and frequent contamination by large
numbers of adaptor dimers. To solve these problems, we used a
multi-stage mapping approach to exclude contaminating mole-
cules that could be due to the library preparation kit, prioritise
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alignments to known small RNAs, and take genetic variation into
account.
First, we aligned the known small RNA molecule sequences
against the human reference genome (NCBI build 37), retrieved all
known variants in the mapped regions from the UK10K
sequencing data (July 2011 release, personal communication,
UK10K Consortium), and created an individual sequence of each
small RNA, with variable bases denoted with the corresponding
IUPAC ambiguity codes. We included all mapped regions for
RNAs that mapped to more than one genomic location. We then
created five synthetic reference genomes (all with the ambiguous
bases at variable sites) corresponding to:
1. Contaminating sequences of adaptors, linkers, adaptor-linker,
and adaptor-tag combinations with all possible single nucleo-
tide alterations (mutation, insertion, deletion).
2. Human mature miRNA and miRNA* sequences from
miRBase v17 [7], but using the hairpin sequence to extend
them by up to 3 bp from the 59 end and 5 bp from the 39 end
3. All known and predicted human non-coding RNA sequences
from Ensembl version 63 together with full-length miRBase
hairpin sequences [7,35]
4. All known human non-coding RNA pseudogenes from
Ensembl version 63 [35]
5. Human reference genome (NCBI Build 37)
We mapped reads to these references using BWA [100] (bwa aln
-n 2 -o 1) and with novoalign v. 2.07.11 (http://www.novocraft.
com, parameters -h 60 60 -t30 -s -m -l 16 -R 0 -r A 30). The latter
is aware of sequence ambiguities, but the former was more
sensitive at detecting reads aligning to the contaminating
sequences. We also tested Bowtie [101], but did not use it due
to the inability of the tested version to handle indels.
For the mapping calls, we excluded reads mapping to
contaminating sequence with either method. For both aligners,
we then took all the alignments in the highest stratum of references
(miRNA.ncRNA.pseudogenes.genome), and picked the ones
with the smallest edit distance. Conservatively, we only retained
alignments of a read if both aligners agreed on all the aligned
locations. For reads mapping genome-wide, but not any known
ncRNAs, we created the set of uncharacterised RNA loci covered
by at least one read in at least one sample without gaps, and
assigned reads to their corresponding uncharacterised loci.
Finally, we quantified the expression level of each ncRNA and
unannotated locus by counting the number of reads aligning to it.
If a read mapped between k alternative sequences or loci in one
reference, we added 1/k to the count of each. We trimmed the
data matrix to contain only RNAs that were observed at least 1000
times across all individuals, or at least 100 times in a single
individual. We discarded individuals with less than 500,000
mapped reads. This retained 131 individuals, including 129
individuals with at least 800,000 reads, and 119 individuals with at
least 1,500,000 reads.
This multi-stage approach excludes mapping contaminating
sequences to the reference, avoids allelic imbalance due to ability
to map by incorporating information on genetic variation, and
resolves potential mapping ambiguities to reflect our belief of how
small RNA molecules are generated.
Normalisation
To use the read counts quantitatively, we normalised the data to
have a comparable total number of reads for each individual. We
estimated a size factor s for library j as the median inflation factor
across all genes: sj= mediang (ngj/GMj(ngj)), where GM stands for
the geometric mean, and ngj is the read count of gene g for
individual j as recommended by Anders and Huber [102]. For
further analyses, we used the log2-transformed corrected values
log2(ngj/sj) to account for heteroskedasticity in the data.
Unannotated read overlaps
We downloaded UCSC genome browser [50] tracks for
DNASE hypersensitivity sites, and ENSEMBL gene structures
for human genome version 37, and calculated their total length, as
well as overlap with the loci giving rise to unannotated small RNA
molecules. We calculated the significance of the enrichment of
unannotated regions in the track from the probability of observing
at least as many overlaps of the 701 unannotated regions given the
frequency of bases covered by each track using a standard
binomial test.
Batch effects
We tested for significance of the correlation coefficient r
between covariates and principal components of the raw read
count data as well as log-transformed and normalised data by
calculating a statistic t= r ((12r2)/129)20.5, and calculating the
(two-tailed) probability of observing at least as extreme a value,
and Bonferroni correcting for 131 tests (one for each PC). We
called the correlation significant, if the corrected p-value was less
than 0.05, corresponding to |r|.0.31.
Sequence variation calling
For each sample, we created sorted BAM files from the
alignment output, and called segregating sites using Samtools
v.0.1.12 (samtools pileup –vcf ) [103]. We then combined the list of
all called variable sites across all samples with sites from the
UK10K project (June 2011 release, personal communication,
UK10K Consortium), created pileup files at them for each sample
(samtools pileup –l sites.tab –f ref.fa), and combined all the
information into a single table giving the number of times each
nucleotide was observed in every sample for each site. The sites
were filtered to have information from at least 20 samples, have at
least one sample with at least 10 observed alleles, and have at least
one sample with at least 20% non-reference allele frequency. We
further discarded three sites as likely false positives – one had 23
observed non-reference alleles, with 16 in one sample and no
DNA evidence (see below), and the other two were variants in the
last base of the mature miRNA, consistent with a modified
degradation product. For validating the genotypes using genome
sequencing data, we constructed DNA read pileup files at same
sites for 40 of our samples sequenced in the UK10K cohort. We
called a site to be a DNA polymorphism, if it had at least five DNA
sequencing reads supporting the non-reference allele. An A to I
edit was called if there were no more than two DNA sequencing
reads with a G allele, and both A and G alleles were observed at
least 90% of the samples, implying extreme deviation from Hardy-
Weinberg equilibrium.
Novel miRNA gene calling
We applied the MapMi pipeline [36] to find potential novel
miRNA loci. We retrieved the sequences of unannotated
genomic regions, calculated their corresponding RNA secondary
structure using RNAfold [104], and applied the MapMi classifier
to obtain a structure score s. We calculated the self-containment
score c of hairpins with s.35 as described in [105], and retained
hairpins satisfying s*c.35. We then mapped all reads to the
filtered candidate hairpins using bowtie, allowing for zero
mismatches, and manually assessed the structural characteristics,
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genomic context, and alignment pileup shape for each candidate
hairpin.
Evolutionary analyses
Mammalian conservation scores were downloaded from the
UCSC genome browser [50]. A chi-square test with one degree of
freedom was used to test the deviation of the fraction of highly
expressed (average log-scale expression.10) unconserved (conser-
vation score ,0) genes from expectation. Similar test was used for
highly variable (log scale variability.5) unconserved genes.
RNA correlation analyses
We subtracted off the linear fit of sample covariates (library
batch and multiplexing tag), from the log-transformed, normalised
data, and calculated the Pearson correlation coefficient between
the residual expression levels and other small RNAs, miRNA star
expression levels, and mRNA probe expression levels from [20].
For mRNA levels, we used both raw measurements, as well as
residuals after correcting for global variance components using
PEER. We also tested for correlation with uncorrected expression
levels, and using linear models as described below, but found no
additional enrichment of statistical signal.
miRNA seed enrichment
miRNA binding specificity is controlled through binding of its
seed region (bases 1–8 of the mature miRNA) with seed
complementary regions (SCRs) in the 39 UTR of mRNAs.
Binding is enhanced if a SCR matches the first seed nucleotide
with an adenosine, irrespective of the seed nucleotide [72]. As the
strongest statistical associations have been reported for regions of
length 6, 7 and 8 (the full region), we combined analyses for these
seed lengths.
For each miRNA, we ordered probes and their associated 39
UTRs by correlation of probe expression values to the miRNA,
with correlations calculated in four different ways as described
above. For each possible 8-nucleotide sequence s8 ending in an
adenosine, we considered its middle 6-mer s6, the two constituent
7-mers s7,1 and s7,2 and the 8-mer s8 itself as the seeds. For each of
these four seeds s and given n, we used Sylamer 08-185 [75] to
calculate a hypergeometric p-value pn(s) to assess the extent to
which the number of their SCR incidences in the top n of the
ordered 39 UTRs deviated from the expected. Potential nucleotide
composition biases were accounted for using third order Markov
correction (flag -m 4). The seed enrichment score for s8 was
calculated as maxn(2log10 pn(s6)2log10 pn(s7,1)2log10 pn(s7,2)2log10
pn(s8)) using a grid of values for n.
For each miRNA that produced a ranked list of probes, the null
distribution of observed scores was estimated by fitting an extreme
value distribution for all calculated adenosine-ending 8-mer scores
using the R function fgev from the evd package. For the miRNA
used to generate the list, the significance of its influence on the
mRNA expression was evaluated by testing its seed enrichment
score against the estimated null. q-values were calculated for the
ordered list of miRNA p-values.
Reanalysis of miRNA perturbation experiments
We selected series GSE18651, GSE19737, GSE27718,
GSE14507 from the Gene Expression Omnibus [106] in which
a particular miRNA was directly perturbed, either by knockdown
or overexpression. We downloaded the normalized expression
data using Bioconductor package GEOquery [107], and per-
formed differential expression analysis using limma [108] to sort
the genes according to fold-change in response to the perturbation.
We first validated that the mRNA expression changes actually
represent the direct effect of a miRNA on its targets. To do so we
used Sylamer [75] to search for enrichment of seed-matches in the
39UTR sequences in the appropriate portion of the genelist, i.e. in
knockdown experiments targets should be up-regulated, upon
overexpression targets should be down-regulated. We then
obtained the targets of each miRNA according to TargetScan
v5 [109], and calculated their median fold-change in the
corresponding experiment. We tested different sets of targets,
prioritizing by evolutionary conservation (PCT) or by context-
score, and selecting the 150 targets with the best scores. In all cases
the median fold-change of these target sets was quite low,
representing changes of 5–38%. Selecting more targets led to a
reduction in the median fold-change. We also calculated the
median fold-change of all possible targets, taking the full set of
transcripts with at least a 7mer seed-match in their 39UTR. These
larger sets had the lowest median fold-changes, representing a 2–
8% change in expression. All this confirms the notion that
miRNAs do not act as on-off switches on the majority of their
targets. Even in experiments that dramatically alter miRNA
abundance, the average effect upon targets is modest.
Genotype and phenotype associations
Associations between snoRNA and miRNA expression and
mean genotypes (expected minor allele count under IMPUTE
posterior probabilities, MAF.5%, IMPUTE info value.0.8) or
phenotypes were tested using a linear model implemented in R
[97]. Cis-eQTL analysis was limited to SNPs located within
100 kB either side of the transcript. The linear model was adjusted
for age, multiplex tag and library batch. The significance of the
genotype or phenotype effect was calculated from the Chi-square
distribution with 1 degree of freedom using 22log(likelihood ratio)
as the test statistic. False discovery rate (FDR) was calculated using
the qvalue package implemented in R 2.11 [97]. Corrections for
multiple testing were done using q-values to control the false
discovery rate (FDR) at 5%. To calculate the FDR, the
associations between the 591 small RNAs and all the cis-located
SNPs for each small RNA, were considered.
To test for difference in small RNA expression between obese
(BMI.30) and lean (BMI,25) individuals we treated BMI, for
subjects falling into one of the two BMI groups, as a binary
categorical variable. Linear models where fitted with small RNA
expression level as response variable and the lean/obese categor-
ical variable as the predictor while adjusting for relevant covariates
(age, library batch, multiplex tag). Significance of the effect size
estimates of the lean/obese predictor was determined by a
likelihood ratio test, and FDR was calculated using the qvalue
package.
Supporting Information
Dataset S1 Novel miRNA gene calls. The fields in the first line
of the file are: [Query#] [Sequence] [Reference] [window
extension side (internal)] [number of mature mismatches]
[chromosome] [strand] [mature start] [mature end] [mature
length] [hairpin start] [hairpin end] [hairpin length] [stem
matches (internal)] [Minimal free energy] [MapMi score] [Self-
containment score]. E.g, the line #Query453204 TTTTGT-
GTGTCAGGGTGCAGG Homo_sapiens left 0 14+94580022
94580042 21 94579957 94580072 115 49245.7000007629395
64.0318185632879 0.772222222222 corresponds to a new micro-
RNA candidate with sequence TTTTGTGTGTCAGGGTG-
CAGG of length 21 (human chromosome 14:94580022–
94580042+strand, in the enclosing 115-nt hairpin with 49 internal
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stem matches at chr14:94579957–94580072). The hairpin has
minimum free energy of 245.7, MapMi score of 64.03, and self-
containment score of 0.77. The rest of the lines give: 1) observed
short-reads mapping to the candidate hairpin without mismatches,
and the lane/tag combinations they were observed in 2) a text-
based histogram of reads mapped to the hairpin to demonstrate
the characteristic camel shape 3) the minimum free energy RNA
structure.
(ZIP)
Figure S1 Data analysis pipeline. Red boxes indicate new data
and results produced in this study, blue boxes are existing data,
and text labels describe tools used to arrive at the data.
(PDF)
Figure S2 Validation of eQTL p-values. Log10 p-value of a
miRNA eQTL in our study (x-axis) is plotted against the eQTL p-
value for the same gene in the replication cohort as reported in
[22]. Each point represents a single miRNA gene.
(PDF)
Figure S3 Summaries of small RNA expression levels most
strongly associated with metabolic traits stratified by BMI. Each
plot contains smoothed densities of expression levels of a single
small RNA for lean (BMI,25), obese (BMI.30), and remaining
individuals (blue areas). A box plot is given by a black line (25th
and 75th percentiles), and the median (white dot).
(PDF)
Figure S4 Summaries of small RNA expression levels most
strongly associated with metabolic traits stratified by fasting
insulin. Each plot contains smoothed densities of expression levels
of a single small RNA for individuals with low (,60) and high
(.60) fasting insulin (blue areas). A box plot is given by a black line
(25th and 75th percentiles), and the median (white dot).
(PDF)
Figure S5 Densities of Pearson correlation coefficients of log-
transformed, normalised miRNA expression levels. Top row - all
pairwise correlations. Bottom row - correlations within clusters
defined by Saini et al. [68]. First column - log-transformed,
normalised data. Second column - log-transformed, normalised
data, corrected for fixed batch effects using a linear model. Third
column - log-transformed, normalised data, corrected for fixed
batch effects and after applying Bayesian factor analysis.
(PDF)
Figure S6 Densities of Pearson correlation coefficients between
log-transformed, normalised miRNA expression levels and mRNA
levels from the same RNA samples. Top - set of correlations
between miRNA genes and their five nearest probes. Bottom -
histogram of a random subset of correlations between miRNA
genes and mRNA genes.
(PDF)
Figure S7 Densities of Pearson correlation coefficients of log-
transformed, normalised miRNA expression levels and their target
mRNA expression levels. Top row - all pairwise correlations of
miRNAs and their targets. Bottom row - random subset of all
pairwise correlations between miRNAs and mRNAs. First column
- TargetScan prediced targets. Second column - Biolead known
targets.
(PDF)
Figure S8 Scatter plot of mature miRNA and alternative arm
(star sequence) expression. Each blue data point corresponds to
one miRNA that had expression of both arms quantified. Average
log-transformed normalised read counts are plotted for the mature
sequence (x-axis) and the alternate arm (previously known as star
sequence, y-axis). Line y = x is plotted in red for comparison.
(PDF)
Table S1 Raw read counts for known RNAs. Every row
corresponds to one quantified RNA molecule. The first seven
columns describe the RNA - its common name (column 1),
accession number (if applicable, column 2), internal ID (column 3),
chromosome (column 4), start coordinate (column 5), end
coordinate (column 6), and small RNA type (column 7). The rest
of the columns each correspond to one individual in the cohort.
The entries in the columns are the raw read counts from mapping,
before normalisation, obtained as described in Materials and
Methods.
(XLS)
Table S2 Raw read counts for unannotated RNAs. Every row
corresponds to one quantified RNA molecule previously unanno-
tated. The first two columns describe the RNA - its location
([chromosome]_[start]_[end], column 1), and type (column 2).
The rest of the columns each correspond to one individual in the
cohort. The entries in the columns are the raw read counts from
mapping, before normalisation, obtained as described in Materials
and Methods.
(XLS)
Table S3 Small RNA level comparisons between tissues. Every
row corresponds to one quantified small RNA molecule. The first
columns is the RNA ID. The next two columns are the mean and
variance of the log-transformed normalised RNA expression level
in the adipose tissue measured in this study. Next, for each
compared tissue, five statistics are given—average expression,
variance of expression, Z score for difference from the mean
adipose expression, p-value of the Z score using a two-tailed
normal distribution, FDR for the Z-score, and q-value for the Z-
score. The final five columns give the average T statistic of
comparing the means of other tissues to the adipose tissue, number
of tissues the p-value was significant in, median p-value, maximum
q-value, and sum of q-values.
(XLS)
Table S4 List of identified polymorphisms and RNA edits. Each
row corresponds to one variant. The columns contain RNA_name
(column 1), miRBase_ID (if applicable, 2) SNP_position in the
RNA (3), reference_allele (4), derived_allele (5), variant type (6),
number of total observed alleles (7), total number of observed_-
reads covering the site (8), number of observed derived_alleles (9),
number of observed reads with the derived allele (10), derive-
d_allele_frequency (11), and frequency of reads with the derived
allele (12).
(XLS)
Table S5 List of identified discrepancies between genomic
sequence and RNA end sequence. Each row corresponds to one
discrepancy. The columns contain RNA_name (column 1),
miRBase_ID (if applicable, 2), internal RNA ID (3), position of
the modification in the RNA (4), location of the modification (5
prime or 3 prime end, 5), RNA base adjacent to the modification
(6), modification sequence (7), number of libraries the modification
was observed in (8), median frequency of modification across
libraries (9), median raw RNA read count (10).
(XLS)
Table S6 Log-transformed, normalised read counts for known
RNA loci. Same as Table S1, but log2-transformed, and
normalised across samples.
(XLS)
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Table S7 Log-transformed, normalised read counts for unan-
notated RNA loci. Same as Table S2, but log2-transformed, and
normalised across samples.
(XLS)
Table S8 miRNA eQTL replication p-values. Each row
corresponds to one miRNA eQTL determined in our study, for
which we give miRNA accession (column 1), name (2), eQTL SNP
ID (3), and eQTL p-value (6). For miRNAs also assayed by
Rantalainen et al. [22], we give the replication SNP (4), replication
p-value (7), and correlation between the original and replication
SNPs (5).
(XLS)
Table S9 Anthropometric characterisation of the cohort.
Summaries of mean, SD, and range are given for each of the
measured traits. * 21 individuals did not have the PTFM
measurements. 1 Insulin values ,13 (the detection limit of the
assay) were set to 12 in analyses
(XLS)
Table S10 Targets of miRNAs associated with metabolic traits.
For each mirna, the BioLead and TargetScan targets are listed.
For each of the lists, we applied g:Profiler [56] with hierarchical
sorting and 1e-10 significance cutoff to produce enriched GO
categories.
(XLS)
Table S11 Small RNA expression difference between lean and
obese individuals. Each row corresponds to one significant (q-
value,0.05) association. The columns give the name (column 1),
miRBase ID (if applicable, 2), p-value (3), q-value (4) and log
likelihood ratio of the linear model fit.
(XLS)
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